A recent study indicates that individuals who stop using popular GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds far faster than those who halt conventional lifestyle plans.
Findings released in a major health publication demonstrates that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these medications need to be cognizant of the potential of quick weight regain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain implies a reversion to starting mass in about one and a half years.
Comparing Approaches
The analysis, which examined 37 of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists point out that individuals who lose weight through diet and exercise typically have a slower weight regain—around 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Experts propose the mode of action of the injections explains the accelerated weight return.
These medications copy a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of GLP-1 levels several times higher than normal may cause the system to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this GLP-1 'fix' leads to hunger is unsuppressed, making binge eating much more probable."
An Ongoing Disease?
The NHS suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts argue that, given the significant potential of relapse, the therapy should be considered ongoing.
This view is reinforced by drug manufacturers, who note that the results "underscore the persistent character of obesity," comparing it to managing diseases like diabetes.
User Experiences
Individuals who have stopped the jabs report a intense resurgence of hunger.
"It was like a trigger flipping and you become ravenous," said one woman.
This challenge is exacerbated if patients have not established lasting dietary or behavioural modifications during treatment.
Widespread Interest
Recent estimates show that a significant number of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is greater among women than males.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, experts caution that while the jabs are effective agents for weight loss, they are not a permanent solution and long-term success hinges on ongoing lifestyle changes.
